Kadenwood Raises $50M to Accelerate Leadership Position in Shaping CBD Into Mainstream Wellness Category
Ryan Allway
June 30th, 2021
News
The Craftory, Arcadian Capital and Existing Investors Led the Series B Round as Kadenwood Expands Its Global Presence & Distribution Network with Recent Acquisitions Including Healist Advanced Naturals and Social CBD
NEWPORT BEACH, Calif., June 29, 2021 /PRNewswire/ — Kadenwood, a leading plant-based wellness company dedicated to fostering consumer trust and transparency, has raised $50 million of cash and media value in a Series B fundraising round with global purpose-led investment house The Craftory and Arcadian Capital Management, and follow-on investments from existing investors. Already the largest U.S. supplier of vertically-integrated CBD consumer packaged goods, this latest funding round further accelerates the brand’s mission to normalize CBD in health and wellness products through scale, strategic partnerships and acquisitions.
In just the first half of 2021, Kadenwood has made a number of high-profile acquisitions, including CBD wellness brands Healist Advanced Naturals and Social CBD. Kadenwood’s organic growth and acquisition approach is creating the largest retail CBD distribution network in the United States, including major drug and grocery store chains, increasing consumer access to trusted CBD products. The acquisition of U.K.-based Healist Advanced Naturals will allow Kadenwood to scale quickly providing new retail and e-commerce distribution channels to bring high-quality CBD to consumers globally. The additional acquisition of Oregon-based Social CBD enables Kadenwood to offer a wider array of products to mass-market consumers across a broad range of demographics as they increasingly look to powerful and plant-based solutions for their health.
Kadenwood had a landmark year of growth in 2020, raising $15 million in a Series A funding round followed by the acquisition of EcoGen Biosciences, the leading global manufacturer and supplier of hemp-derived CBD materials and formulations. The deal effectively established Kadenwood as the largest supplier of vertically-integrated, hemp-derived cannabidiol (CBD) in the US, expanding the company’s ability to scale production of its quality-driven CBD products.
Kadenwood entered the consumer products marketplace in 2019 with a 100% owned seed-to-shelf capability and has grown its family of industry-leading brand portfolio to include LEVEL SELECT™ CBD, in the personal care category, Purity Preferred™ Pet CBD and Purity Organic™ CBD Teas.
“Healist has deep, strong foundations in consumer insights, and understands Sleep, Calm and Relief like no other CBD brand. We will continue our partnership with this bold CPG challenger brand by investing in Kadenwood, as we view them as the perfect home for Healist,” explains Elio Leoni Sceti, Co-Founder & Chief Crafter at The Craftory.
“With this new round of funding, we are accelerating our mission of building enduring CBD brands that people trust as being safe and effective, while cementing our position as a leading global, vertically-integrated CBD company,” said Erick Dickens, Co-Founder and CEO of Kadenwood. “This funding round solidifies our ability to execute a $20M media campaign to drive consumer awareness and support our retail partners with these industry leading brands. We’re incredibly excited by the growth ahead for Kadenwood and our family of brands as we focus on scaling and growing our business while helping shape the future of CBD and plant-based wellness.”
For more information on Kadenwood and its products please visit www.kadenwoodbrands.com or contact Kadenwood@bcw-global.com.
For more information on The Craftory please visit TheCraftory.io or contact thecraftory@sciencemagic.inc
For more information on Healist please visit https://healistnaturals.com/
For more information on Social CBD please visit https://socialcbd.com/
About CBD
CBD is a non-intoxicating cannabinoid found in cannabis. After tetrahydrocannabinol (THC), cannabidiol (CBD) is the second most abundant cannabinoid in the plant and is believed to have many potential therapeutic benefits.
About Kadenwood
Founded in 2019, Kadenwood is a privately held consumer products lifestyle company relentlessly focused on shaping CBD into a trusted and safe mainstream wellness category. To drive this mission, Kadenwood is backed by decades of CPG marketing and category innovation expertise and industry-leading, vertically integrated CBD farming to ensure quality CBD oil from seed-to-shelf that contains 0% THC. In 2019, Kadenwood launched its first plant-based branded products under LEVEL SELECT™ in personal care. And in late 2020, Kadenwood launched the Purity Preferred™ Pet business, as well as Purity Organic® hot teas, to add to its portfolio of CBD brands.
About The Craftory
Based in London and San Francisco, The Craftory is a $375M global investment house focused exclusively on amplifying the world’s boldest consumer brands. We offer permanent, early stage and growth capital to cause-driven CPG brands that positively impact the categories they serve, society, and the planet. The Craftory is a proud B-Corp.
SOURCE Kadenwood
Related Links
http://www.kadenwoodbrands.com
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
About Ryan Allway
Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.
Search CannabisFN
Press Coverage
Psychedelics Index
Top Videos
In addition to his role as Founder and CEO at MAZAKALI, Sumit is a consultant to The Arcview Group and the Managing Partner of Emerald Ventures. A frequent speaker at investment seminars, Sumit acts as a mentor to Arcview and Canopy companies and serves on the Canopy Investment committee as well as the NCIA Finance […]
Tom Zuber is Zuber Lawler & Del Duca’s Managing Partner. He has a degree with highest honors in biomedical engineering and has advised some of the most iconic companies in the world on their patent and trademark portfolios. He is at the cutting edge of cannabis patent and trademark law. He holds degrees from Harvard University and Columbia Law […]
KetamineOne Capital is focused on consolidating medical clinics and becoming a North American leader in mental health treatments.
BDS Analytics aims to drive the cannabis sector to thrive with well-informed decisions based on factual data. By capturing millions of transactions from dispensary point-of-sale systems we provide actionable insights based on accurate information enabling dispensaries, brands, and growers to sustain their success. Their vision is to be your indispensable source for cannabis industry data […]
Network Partners
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.
Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer
